Clinical Study on Intraluminal Injection of FOLactis

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

March 30, 2025

Study Completion Date

May 30, 2026

Conditions
Solid TumorImmune ResponsePleural Effusion, MalignantPeritoneal Effusion
Interventions
OTHER

FOLactis

Evaluate the safety,tolerability, efficacy of intraluminal injection of FOLactis combined with chemotherapy, target therapy, and immunotherapy

Trial Locations (1)

Unknown

RECRUITING

The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Medical School of Nanjing University & Clinical Center Institute of Nanjing University, Nanjing, China, Nanjing

All Listed Sponsors
lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER